Bioequivalence Study of Bosentan 125 mg Tablets Immediate Release (IR) Versus Tracleer® 125 mg Tablets IR In Healthy Subjects
Condition(s):BioequivalenceLast Updated:September 24, 2019Completed
Hide Studies Not Open or Pending
Condition(s):BioequivalenceLast Updated:September 24, 2019Completed
Condition(s):Congenital Heart Defects; Functional Single VentricleLast Updated:August 10, 2012Completed
Condition(s):Drug InteractionsLast Updated:May 31, 2017Completed
Condition(s):Congenital Heart DiseaseLast Updated:December 22, 2015Unknown status
Condition(s):Thromboangiitis ObliteransLast Updated:August 16, 2016Completed
Condition(s):Pulmonary Arterial HypertensionLast Updated:December 11, 2017Completed
Condition(s):Port-wine StainsLast Updated:February 5, 2018Completed
Condition(s):Scleroderma, SystemicLast Updated:December 13, 2018Completed
Condition(s):Scleroderma Renal CrisisLast Updated:July 6, 2016Completed
Condition(s):Ischemic Optic NeuropathyLast Updated:July 7, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.